Showing results (401-410 of 831) with videos related to

Sort By:
Pageof 84
Leukemia Research|July 30, 2013
Modest activity of pomalidomide in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
Blood|March 23, 2006
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemiaCharles Koller, B Nebiyou Bekele, Xian Zhou, et al.
Cancer|October 21, 2010
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromeElias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.
American Journal of Hematology|November 20, 2014
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibodyElias Jabbour, Susan O'Brien, Xuelin Huang, et al.
Cancer|January 20, 2007
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaYasuhiro Oki, Hagop M Kantarjian, Vazganush Gharibyan, et al.
Cancer|February 23, 2007
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experienceHagop M Kantarjian, Susan O'Brien, Xuelin Huang, et al.
Cancer|May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemiaRaoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.
American Journal of Hematology|February 17, 2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcomePreetesh Jain, Michael Keating, Phillip A Thompson, et al.
Blood|May 20, 2006
Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Pageof 84